BeStock  
Markets › Compare › SPTX vs MRVI

SPTX vs MRVI

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
SPTX · Seaport Therapeutics$18.05 ▼ 1.47%
MRVI · Maravai LifeSciences$6.98 ▼ 2.92%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

67113159205251May 1, '26Aug 12, '26Nov 20, '26
  • SPTX -9.0%
  • MRVI +87.1%

Head to head

MetricSPTXMRVI
Price$18.05$6.98
Change today▼ 1.47%▼ 2.92%
Market cap$966.23M$1.04B
Return, 3 months-25.0%-17.2%
Return, year to date–+114.8%
Return, 1 year–+86.1%
P/E (TTM)––
P/B2.45.3
P/E percentile vs own 5y87th0th
Dividend yield––
Revenue growth (YoY, latest qtr)–+10.1%
Net profit growth (YoY)-17.1%+46.7%
Gross margin–39.1%
Operating margin–-25.6%
Net margin–-30.8%
Return on equity-34.9%-29.8%
Analyst target vs. price+107.4%+41.5%
Analyst buy share100%100%
RSI (14)3943
30-day volatility62.8%80.7%
Max drawdown, 1 year-42.2%-29.6%
Trend readStrong downtrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MRVI is the largest of the group by market value.
  • SPTX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top